Leaflet ATOFAB 25mg capsules
- Product code:
- W65387005
- Quantity:
- 30
- Indicated for:
- attention deficit hyperactivity disorder (ADHD)
- Route of administration:
- oral
- Substance:
- atomoxetine (psychostimulant)
- ATC
- N06BA09 — Nervous system | Psychostimulants, agents used for adhd and nootropics | Centrally acting sympathomimetics
Atomoxetine is a selective norepinephrine reuptake inhibitor (sNRI) medication used to treat attention deficit hyperactivity disorder (ADHD) and, to a lesser extent, cognitive disengagement syndrome (CDS).
It may be used alone or along with stimulant medication.
It enhances the executive functions of self-motivation, sustained attention, inhibition, working memory, reaction time, and emotional self-regulation.
Use of atomoxetine is only recommended for those who are at least six years old.
It is taken orally. The effectiveness of atomoxetine is comparable to the commonly prescribed stimulant medication methylphenidate.
Atomoxetine alleviates ADHD symptoms through norepinephrine reuptake inhibition and by indirectly increasing dopamine in the prefrontal cortex, sharing 70-80% of the brain regions with stimulants in their produced effects.
Unlike α2-adrenergic receptor agonists such as guanfacine and clonidine, atomoxetine's use can be abruptly stopped without significant withdrawal symptoms being observed.
It may be used alone or along with stimulant medication.
It enhances the executive functions of self-motivation, sustained attention, inhibition, working memory, reaction time, and emotional self-regulation.
Use of atomoxetine is only recommended for those who are at least six years old.
It is taken orally. The effectiveness of atomoxetine is comparable to the commonly prescribed stimulant medication methylphenidate.
Atomoxetine alleviates ADHD symptoms through norepinephrine reuptake inhibition and by indirectly increasing dopamine in the prefrontal cortex, sharing 70-80% of the brain regions with stimulants in their produced effects.
Unlike α2-adrenergic receptor agonists such as guanfacine and clonidine, atomoxetine's use can be abruptly stopped without significant withdrawal symptoms being observed.
General data about ATOFAB 25mg
- Substance:
- atomoxetine
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W65387005
- Concentration:
- 25mg
- Pharmaceutical form:
- capsules
- Quantity:
- 30
- Product type:
- Generic medicine
- Price:
- 138.39 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for atomoxetine
Concentrations available for atomoxetine
- 100mg
- 10mg
- 18mg
- 25mg
- 40mg
- 4mg/ml
- 60mg
- 80mg